Cardiovascular Diseases, Chronic Disease
Conditions
Keywords
intervention, translation, workplace, CVD, CDSMP
Brief summary
This project is the test of the effectiveness of the Chronic Disease Self-Management Program which will be translated to a worksite setting.
Detailed description
This project will test adaptations of the Chronic Disease Self-Management Program (CDSMP) designed to increase the likelihood of widespread use in workplace settings. CDSMP, which has been proven efficacious in community trials, is a six-week program that is designed to help individuals better manage their chronic disease and its many complications. Although there is considerable interest among worksite health promotion practitioners for a chronic disease program, CDSMP has not been adapted and tested in workplace settings. In this study, we will determine a) if the CDSMP program tailored to worksites can be efficacious, b) the comparative effectiveness of the worksite tailored CDSMP when compared to the original CDSMP and c) the cost-effectiveness (average and incremental) and return on investment of the two interventions. The participating sites are seven organizations from a rural county in Southwest Georgia. Our partner for the project is the local YMCA. YMCA staff will be trained to implement the program which will foster sustainability. Participants will be randomly assigned to 1) workplace-tailored CDSMP, 2) 'usual care' CDSMP, and 3) control group. Data will collected at baseline, 6-month follow-up and 12-months follow-up. The control group will be a delayed intervention group that will be randomly assigned to an intervention group after taking the 6 month survey. The primary outcome measures include blood pressure, cholesterol, blood glucose, BMI, diet, physical activity and tobacco use and the secondary measures including patient-provider communication, quality of life, medical adherence, and work performance and productivity. An average cost-effectiveness analysis will compare interventions to control and an incremental cost-effectiveness analysis will be conducted comparing each intervention to one another. The hypotheses will be tested using a growth modeling approach examining changes over time. This will enable us to maximize the dissemination and implementation of CDSMP across worksite populations by using approaches which are realistic for most work organizations.
Interventions
This is the CDSMP program which has been modified to fit the unique characteristics of the workplace and will be offered in worksites.
This is the standard CDSMP which has been implemented in community settings.
Sponsors
Study design
Eligibility
Inclusion criteria
* The primary target is all employees 45 years or above with levels of gender and ethnicity similar to those found in the workplaces with which we will work. * If younger individuals wish to participate, we will not turn them away but the program is designed for older adults. It is unlikely we will get a substantial number of participants over 45.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sedentary behavior (Measures total time spent sitting in transport, work and leisure) examining change at 6 and 12 months | baseline, six months, one year | Measures total time spent sitting in transport, work and leisure. |
| Physical activity (Measure of moderate-intensity physical activities) examining change at 6 and 12 months | baseline, six months, one year | Measure of moderate-intensity physical activities. |
| Eating behaviors (Food propensity questionnaire) examining change at 6 and 12 months | baseline, six months, one year | Food propensity questionnaire used to estimate usual intake for food items and food groups. |
| Cardiovascular risk scale examining change at 6 and 12 months | baseline, six months, one year | Overall measure taken from the Framing Heart Study which includes: systolic blood pressure, total cholesterol, HDL cholesterol, BMI, gender, age, use of antihypertensive treatment, smoking and diabetes mellitus status. |
| Body Mass Index examining change at 6 and 12 months | baseline, six months, one year | Measure of obesity using height and weight |
| blood glucose examining change at 6 and 12 months | baseline, six months, one year | blood glucose levels |
| Cholesterol levels examining change at 6 and 12 months | baseline, six months, one year | HDL, LDL, and total cholesterol levels |
| blood pressure examining change at 6 and 12 months | baseline, six months, one year | diastolic and systolic measures |
| Tobacco use examining change at 6 and 12 months | baseline, six months, one year | Measure of current and past tobacco use. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of life (EQ-5D) scale examining change at 6 and 12 months | baseline, six months, one year | Measure of quality of life (EQ-5D). |
| Sleep (Visual analogue scale) examining change at 6 and 12 months | baseline, six months, one year | Visual analogue scale to determine symptoms of chronic disease. |
| Patient-provider communication (Measure of communication with a physician) examining change at 6 and 12 months | baseline, six months, one year | Measure of communication with a physician. |
| Self-assessed quality of life scale examining change at 6 and 12 months | baseline, six months, one year | CDC Healthy Days quality of life measure. |
| Depression (Personal Health Questionnaire Depression Scale (PHQ8) examining change at 6 and 12 months | baseline, six months, one year | Personal Health Questionnaire Depression Scale (PHQ8). |
| Prescription medication adherence examining change at 6 and 12 months | baseline, six months, one year | Measures medication compliance. |
| Pain (Visual analogue scale) examining change at 6 and 12 months | baseline, six months, one year | Visual analogue scale to determine symptoms of chronic disease. |
| Stress (Visual analogue scale) examining change at 6 and 12 months | baseline, six months, one year | Visual analogue scale to determine symptoms of chronic disease. |
| Fatigue (Visual analogue scale) examining change at 6 and 12 months | baseline, six months, one year | Visual analogue scale to determine symptoms of chronic disease. |
| Well-being (SF-12) scale examining change at 6 and 12 months | baseline, six months, one year | Measure of functional health and well-being (SF-12). |
Other
| Measure | Time frame | Description |
|---|---|---|
| Absenteeism scale examining change at 6 and 12 months | baseline, six months, one year | Measures absence, lateness, and performance. |
| Healthcare utilization (Self-report measures) examining change at 6 and 12 months | baseline, six months, one year | Self-report measures of physician and hospital services. |
| Fatigue (Work-related fatigue assessment scale.) examining change at 6 and 12 months | baseline, six months, one year | Work-related fatigue assessment scale. |
| Job stress scale examining change at 6 and 12 months | baseline, six months, one year | Measures job-related stress. |
| Turnover intention question examining change at 6 and 12 months | baseline, six months, one year | Measures likelihood of leaving the organization. |
| Organizational commitment scale examining change at 6 and 12 months | baseline, six months, one year | Measures organizational commitment. |
| Job satisfaction question examining change at 6 and 12 months | baseline, six months, one year | Measures job satisfaction. |
| Work ability index examining change at 6 and 12 months | baseline, six months, one year | Assess physical and mental demands of work and worker's health status and resources. |
| Presenteeism (Work Limitations Questionnaire (WLQ) examining change at 6 and 12 months | baseline, six months, one year | Work Limitations Questionnaire (WLQ) assess the degree to which health problems interfered with job activities. |
Countries
United States